ethinyl estradiol has been researched along with Sclerosis, Systemic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Avis, M; Gahlemann, M; Guillén-Del-Castillo, A; Kreuter, M; Mack, SR; Marzin, K; Vonk, MC; Wind, S | 1 |
| THORNE, N | 1 |
2 other study(ies) available for ethinyl estradiol and Sclerosis, Systemic
| Article | Year |
|---|---|
A Drug-Drug Interaction Study to Investigate the Effect of Nintedanib on the Pharmacokinetics of Microgynon (Ethinylestradiol and Levonorgestrel) in Female Patients with Systemic Sclerosis-Associated Interstitial Lung Disease.
Topics: Antineoplastic Agents; Area Under Curve; Contraceptive Agents, Hormonal; Drug Combinations; Drug Interactions; Ethinyl Estradiol; Europe; Female; Humans; Indoles; Levonorgestrel; Lung Diseases, Interstitial; Middle Aged; Scleroderma, Systemic; United States | 2022 |
SCLERODERMA.
Topics: Drug Therapy; Ethinyl Estradiol; Humans; Prednisolone; Scleroderma, Systemic | 1964 |